Treatment Approach to Severe Ocular Surface Disease | ASCRS
Menu
Home Clinical Education Cornea Treatment Approach to Severe Ocular Surface Disease
Presentation
Treatment Approach to Severe Ocular Surface Disease
April 2022
Meeting: 2022 ASCRS Cornea Day
Session: CD-3 - Session III: Ocular Surface
Presenter: Edward J. Holland, MD
This content is only available for ASCRS Members

ASCRS Membership offers access to 1,000+ educational resources on demand.

Filed Under
Cornea ocular surface disease stem cell deficiency limbal stem cell deficiency Boston Kpro KLAL keratolimbal allograft
View More Presentations from CD-3

This presentation is from the session "CD-3 - Session III: Ocular Surface" from the 2022 ASCRS Cornea Day held on April 22, 2022 in Washington, DC.

View More From This Session
Browse All 2022 ASCRS Subspecialty Day On Demand

Related Content

Session
IC-308 Ocular Surface Disease: Medical Optimization and Surgical Interventions
Clara C. Chan, MD, FRCS; David Rootman, MD, FRCSC; Allan Siomovic, MD, FRCSC; Neera Singal, MD, FRCSC; Joshua Teichman, MD, FRCSC; Larissa Gouvea, MD; Sara AlShaker, MD, FRCSC; Nizar Din, FRCOphth; Shai Gendler, MD 1:31:31 minutes
April 2022
Session
SPS-205 Ocular Surface Disease II
1:40:51 minutes
April 2022
Presentation
Differentiating and Treating the Red Eye: Allergy, Episcleritis and Scleritis
Soroosh Behshad, MD, ABO 06:22 minutes
July 2021
Session
SPS-119 Ocular Surface Disease
1:21:23 minutes
May 2023
American
About ASCRS
Clinical Education
Meetings
Tools
ASCRS foundation
Donate
Contact Us

© 2024 ASCRS. All Rights Reserved.

Advertise Legal Notice

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.